SCIENCEBRING   /   HAMBURG, GERMANY
International Journal of Advance Scientific Research SCIENTIFIC IDEAS. INTERNATIONAL PERSPECTIVES.
ISSN 2750-1396 12 issues per year · Monthly
Crossref DOI: 10.37547/ijasr

Search the Journal

Articles Published:

Green Technologies in The Pharmaceutical Industry: Modern Approaches to Ecologically Safe Drug Manufacturing

Vol. 6 No. 08 (2026): Volume 06 Issue 08 Pages 236-241
DOI 10.37547/ijasr-06-08-15 ↗
RESEARCH OVERVIEW

Abstract

The pharmaceutical industry provides essential medicines and contributes substantially to public health, yet its manufacturing processes may consume significant amounts of energy, water, solvents and raw materials and can generate complex waste streams. Green technologies offer a pathway to reduce these environmental burdens without compromising pharmaceutical quality, safety or efficacy. This article reviews contemporary approaches to greener pharmaceutical manufacturing, including green chemistry, solvent selection, process intensification, continuous manufacturing, renewable energy, water conservation, waste minimization, sustainable packaging and responsible management of unused medicines. Particular attention is given to the application of the principles of prevention, safer synthesis and resource efficiency throughout the pharmaceutical product life cycle. The article also considers the role of pharmacists and pharmaceutical organizations in promoting environmentally responsible practices. Implementation of green technologies requires cooperation among scientists, manufacturers, regulators and healthcare professionals, as well as appropriate economic and educational incentives. Integrating environmental considerations into pharmaceutical development can contribute to cleaner production, more efficient resource use and long-term sustainability of the healthcare system.

Keywords

SOURCES & CITATIONS

References

1. Anastas, P. T., & Warner, J. C. (1998). Green Chemistry: Theory and Practice. Oxford University Press.
2. Sheldon, R. A. (2017). The E factor: fifteen years on. Green Chemistry, 19, 18–43.
3. Jiménez-González, C., Ponder, C. S., Broxterman, Q. B., & Manley, J. B. (2004). Using the right green yardstick: Why process mass intensity is used in the pharmaceutical industry. Organic Process Research & Development, 8(6), 939–945.
4. Constable, D. J. C., Curzons, A. D., Cunningham, V. L., et al. (2002). Green chemistry and sustainability in the pharmaceutical industry. Green Chemistry, 4, 521–527.
5. International Council for Harmonisation (ICH). (2023). ICH Q13: Continuous Manufacturing of Drug Substances and Drug Products.
6. U.S. Environmental Protection Agency (EPA). (2024). Green Chemistry and Safer Choice: Principles and approaches for pollution prevention.
7. World Health Organization (WHO). (2019). WHO good manufacturing practices for pharmaceutical products: main principles.
8. European Medicines Agency (EMA). (2024). Environmental risk assessment of medicinal products for human use: scientific guidance.
DISCOVER RELATED RESEARCH

Similar Articles

Continue exploring the collection ↗
21-30 of 72